Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
IL-6 in Checkpoint Myocarditis: A Promising Biomarker and Therapeutic Target.
Journal: JACC. CardioOncology
Published: May 09, 2026
Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors.
Journal: Nature cardiovascular research
Published: December 18, 2023
The HDAC9-associated risk locus promotes coronary artery disease by governing TWIST1.
Journal: PLoS genetics
Published: October 20, 2021
Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis.
Journal: eLife
Published: February 27, 2021
miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques.
Journal: Circulation research
Published: February 17, 2021
Characterization of Myocardial Injury in Patients With COVID-19.
Journal: Journal of the American College of Cardiology
Published: May 26, 2020
Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Journal: Circulation research
Published: April 28, 2020
Takotsubo Cardiomyopathy in COVID-19.
Journal: Journal of the American College of Cardiology
Published: April 24, 2020
Myocardial infarction accelerates breast cancer via innate immune reprogramming.
Journal: Nature medicine
Published: September 24, 2019
Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.
Journal: JCI insight
Published: August 29, 2018
Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression.
Journal: Frontiers in cardiovascular medicine
Published: December 16, 2017
microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 14, 2016
Last Updated: 09/26/2026